Skip to main content
. Author manuscript; available in PMC: 2013 Aug 9.
Published in final edited form as: Virology. 2008 Sep 18;380(2):285–295. doi: 10.1016/j.virol.2008.07.007

Fig. 6.

Fig. 6

Lack of effect of anti-CD4bs mAbs b12 and F105 on neutralization of JRFL by mAb 447-52D and GP vaccine serum 82-4. Unlike sCD4, which increases neutralization sensitivity of JRFL to anti-V3 antibodies, b12 and F105 did not affect neutralization sensitivity of JRFL to anti-V3 antibodies. The IC50 and IC80 of sCD4, b12 and F105 against JRFL are indicated on the X-axes.